EUVIMEDEUVIMED entdecken
Crossref

Qidong Huoxue Yin modulates gut microbiota and microbial metabolism to attenuate inflammation in lipopolysaccharide (LPS)-induced acute lung injury

Wanting SU, Wei LIU, Yongjun ZHANG, Tian ZHAO, Wu YE, Juan LIU, Li LI, Zhijun LI

Bioscience of Microbiota, Food and Health · 2026

DOI: 10.12938/bmfh.2026-039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioscience of Microbiota, Food and Health, 2026. Verfasst von Wanting SU und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to investigate the potential role of Qidong Huoxue Yin (QDHXY), a traditional herbal formulation, in modulating gut microbiota and microbial metabolism in lipopolysaccharide (LPS)-induced acute lung injury (ALI). An ALI mouse model was established via endotracheal administration of LPS, and an in vitro fermentation system using human fecal microbiota was employed to further explore microbial responses. QDHXY administration was associated with reduced levels of pro-inflammatory cytokines (TNF-α and IL-1β) and increased levels of anti-inflammatory IL-10 in mice. Meanwhile, QDHXY altered the gut microbiota composition, characterized by increased abundance of Akkermansia and decreased abundance of Lactobacillus in vivo. In vitro fermentation results further indicated that QDHXY was associated with changes in microbial community structure, with increased abundance of Lactobacillus and decreased abundance of Escherichia-Shigella. Additionally, QDHXY was associated with reduced production of potentially harmful gases (NH₃, H₂, and H₂S) and changes in microbial metabolites, including acetic acid, kaempferol, and 3-hydroxyphenylacetic acid. Notably, the differential responses of Lactobacillus between in vivo and in vitro systems suggest context-dependent microbial modulation. These findings suggest that QDHXY may attenuate inflammation in ALI through microbiota–metabolite interactions rather than direct causal mechanisms.

Zitieren

APA

SU, W., LIU, W., ZHANG, Y., ZHAO, T., YE, W., LIU, J., LI, L., & LI, Z. (2026). Qidong Huoxue Yin modulates gut microbiota and microbial metabolism to attenuate inflammation in lipopolysaccharide (LPS)-induced acute lung injury. Bioscience of Microbiota, Food and Health. https://doi.org/10.12938/bmfh.2026-039

Vancouver

SU W, LIU W, ZHANG Y, ZHAO T, YE W, LIU J, et al. Qidong Huoxue Yin modulates gut microbiota and microbial metabolism to attenuate inflammation in lipopolysaccharide (LPS)-induced acute lung injury. Bioscience of Microbiota, Food and Health. 2026. doi:10.12938/bmfh.2026-039

BibTeX
@article{SU2026,
  author = {SU, Wanting and LIU, Wei and ZHANG, Yongjun and ZHAO, Tian and YE, Wu and LIU, Juan and LI, Li and LI, Zhijun},
  title = {Qidong Huoxue Yin modulates gut microbiota and microbial metabolism to attenuate inflammation in lipopolysaccharide (LPS)-induced acute lung injury},
  journal = {Bioscience of Microbiota, Food and Health},
  year = {2026},
  doi = {10.12938/bmfh.2026-039}
}
Kostenlos starten →